These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 26133181)
1. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice. Gupta T; Shirsat N; Jalali R Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181 [TBL] [Abstract][Full Text] [Related]
2. Molecular biology of medulloblastoma: bridging the gap between research and practice. Gupta T; Jalali R Expert Rev Neurother; 2011 Apr; 11(4):491-4. PubMed ID: 21469921 [TBL] [Abstract][Full Text] [Related]
3. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Kunder R; Jalali R; Sridhar E; Moiyadi A; Goel N; Goel A; Gupta T; Krishnatry R; Kannan S; Kurkure P; Deopujari C; Shetty P; Biyani N; Korshunov A; Pfister SM; Northcott PA; Shirsat NV Neuro Oncol; 2013 Dec; 15(12):1644-51. PubMed ID: 24203893 [TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma in the age of molecular subgroups: a review. Juraschka K; Taylor MD J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples. D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195 [TBL] [Abstract][Full Text] [Related]
6. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres. Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222 [TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of medulloblastoma molecular subgroups. Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292 [TBL] [Abstract][Full Text] [Related]
8. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823 [TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy. Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704 [TBL] [Abstract][Full Text] [Related]
10. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Kool M; Korshunov A; Remke M; Jones DT; Schlanstein M; Northcott PA; Cho YJ; Koster J; Schouten-van Meeteren A; van Vuurden D; Clifford SC; Pietsch T; von Bueren AO; Rutkowski S; McCabe M; Collins VP; Bäcklund ML; Haberler C; Bourdeaut F; Delattre O; Doz F; Ellison DW; Gilbertson RJ; Pomeroy SL; Taylor MD; Lichter P; Pfister SM Acta Neuropathol; 2012 Apr; 123(4):473-84. PubMed ID: 22358457 [TBL] [Abstract][Full Text] [Related]
11. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851 [TBL] [Abstract][Full Text] [Related]
12. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients. Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693 [TBL] [Abstract][Full Text] [Related]
13. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup. da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781 [TBL] [Abstract][Full Text] [Related]
15. Subgroup-specific alternative splicing in medulloblastoma. Dubuc AM; Morrissy AS; Kloosterhof NK; Northcott PA; Yu EP; Shih D; Peacock J; Grajkowska W; van Meter T; Eberhart CG; Pfister S; Marra MA; Weiss WA; Scherer SW; Rutka JT; French PJ; Taylor MD Acta Neuropathol; 2012 Apr; 123(4):485-499. PubMed ID: 22358458 [TBL] [Abstract][Full Text] [Related]
16. Molecular subgroups of medulloblastoma: the current consensus. Taylor MD; Northcott PA; Korshunov A; Remke M; Cho YJ; Clifford SC; Eberhart CG; Parsons DW; Rutkowski S; Gajjar A; Ellison DW; Lichter P; Gilbertson RJ; Pomeroy SL; Kool M; Pfister SM Acta Neuropathol; 2012 Apr; 123(4):465-72. PubMed ID: 22134537 [TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199 [TBL] [Abstract][Full Text] [Related]
18. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile. Sadighi Z; Vats T; Khatua S J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514 [TBL] [Abstract][Full Text] [Related]